Lake Street analyst Ben Klieve reiterated a Buy rating on The Andersons (ANDE – Research Report) today and set a price target of $60.00. The company’s shares closed last Wednesday at $39.47.
Klieve has an average return of 24.6% when recommending The Andersons.
According to TipRanks.com, Klieve is ranked #454 out of 7991 analysts.
The Andersons has an analyst consensus of Moderate Buy, with a price target consensus of $52.50.
See the top stocks recommended by analysts >>
The Andersons’ market cap is currently $1.24B and has a P/E ratio of 13.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Andersons, Inc. is an agricultural rooted diversified company, which engages in railcar leasing and repair, turf products production, and consumer retailing. It operates through the following business segments: Trade, Ethanol, Plant Nutrient, and Rail. The Trade segment specializes in the movement of physical commodities such as whole grains, grains products, feed ingredients, frac sand, domestic fuel products, and other agricultural commodities. The Ethanol segment purchases and sells ethanol; offers facility operations, risk management, and ethanol and corn oil marketing services. The Plant Nutrient segment manufactures, distributes, and retails agricultural plant nutrients; corncob-based products; and pelleted lime and gympsum products. The Retail segment leases, repairs, and sells various types of railcars, locomotives and barges. The company was founded by Harold Anderson and Margaret Anderson in 1947 and is headquartered in Maumee, OH.
Read More on ANDE:
- Analysts Offer Insights on Technology Companies: Infinera (INFN) and Ping Identity Holding (PING)
- Match Group Down 17% as Revenue Misses, New Developments Paused
- Echelon Wealth Partners Thinks Bunker Hill Mining’s Stock is Going to Recover
- Perion Network (PERI) Received its Third Buy in a Row
- Berenberg Bank Sticks to Its Hold Rating for Alnylam Pharma (ALNY)
